THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA

THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA Our Mission The Silverstein Foundation for Parkinson’s with GBA began with the goal of aggressively seeking out new, cutting-edge therapeutic approaches to treating and preventing Parkinson’s in GBA mutation carriers; we are now focusing our efforts on the fellowship program which aims to find and foster the next generation of GBA-PD researchers. We also engage with clinicians, scientists, academic laboratories and private biotechnology companies to accelerate research and clinical trials in an effort to rapidly bring new therapeutic options to patients. Our Global Reach The Silverstein Foundation for Parkinson’s with GBA is incredibly proud of all of our fellows. + 26 fellows + 17 institutions + 7 countries The 2025 Class of Silverstein Fellows Dr. Sinead Greally Harvard Medical School and Boston Children’s Hospital Dr. Daniele Mattei Icahn School of Medicine at Mount Sinai New York Dr. Noemi Asfogo University of Luxembourg Dr. Alberto Imarisio University of Pavia Dr. Julia Billups Harvard Medical School and Brigham & Women’s Hospital Dr. Camille Lacarrière-Keïta McGill University Dr. Jeffrey Kim Baylor College of Medicine Dr. Thao Nguyen-Tran University of Ottawa Dr. Linda Montavoci University of Oxford Dr. Georgia Minakaki Feinberg School of Medicineat Northwestern University Dr. Hannah Clarke University College London Dr. Zhijun Zhu Stanford University Dr. Shachar Shani Tel Aviv Sourasky Medical Center and Tel Aviv University Dr. Jade Park Mount Sinai Beth Israel in New York City Dr. Giulia Pedrotti The Institute for Biomedicine of Eurac Research in Bolzano, Italy The 2023 Class of Silverstein Fellows Dr. Oriol Narcis Icahn School of Medicine at Mount Sinai New York Dr. Irina Alecu University of Ottawa Dr. Areej Mesleh Qatar University Dr. Sydney Reitz Harvard Medical School and Brigham & Women’s Hospital Dr. Daan Van Kruining University of Oxford Dr. Jinghan Zhao Baylor College of Medicine Dr. Manoj Kumar University of Maryland Dr. Aleksandra Levina Stanford University Dr. Casey Young Mount Sinai in New York Dr. Bernabe Bustos Northwestern University Dr. Gadi Maayan Eshed Tel Aviv Sourasky Medical Center The Silverstein Foundation’s Scientific Advisory Board ASA ABELIOVICH, M.D. PH.D. CEO, President and Founder of Leal Therapeutics ROY ALCALAY, M.D. Chief of the Movement Disorders Division at Tel Aviv Sourasky Medical Center PETER T. LANSBURY, JR., PH.D. Professor of Neurology at Harvard Medical School GREGORY GRABOWSKI, M.D. Professor Emeritus of Pediatrics and Genetics at the Cincinnati Children’s Hospital Research Foundation KARL KIEBURTZ, M.D. MPH Professor of Neurology at the University of Rochester, and President of Clintrex Research Corporation DIMITRI KRAINC, M.D. PH.D. Professor and Chairman of the Department of Neurogenetics at Northwestern University JIM SULLIVAN, PH.D. CEO of Vanqua Bio PETER THOMPSON, M.D. General Partner of OrbiMed January 21st Fellowship Meeting